Seattle’s Parse Biosciences to be acquired by Qiagen for $225M Seattle’s Parse Biosciences is teed up for an acquisition by Qiagen, a Netherlands-based holding company, in a $225 million cash… Read More
The ‘golden age’ for research tools: Parse Biosciences raises $41.5M for single-cell tech Alex Rosenberg was a postdoc at the University of Washington when he co-founded a new biotech startup in 2018 and… Read More
University of Washington spinout Split Bio raises cash for RNA sequencing kits University of Washington spinout Split Bio raised $560,000 in bridge financing to fund the manufacturing of kits that allow scientists… Read More
